| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8794568 | Ophthalmology Retina | 2018 | 11 Pages |
Abstract
Our study supports the role of HRM as an important biomarker for the evolution of macular scar and atrophy in patients with nAMD undergoing treatment with anti-VEGF therapies. Undefined HRM can resolve with treatment, whereas well-defined HRM likely contains vascular complexes and fibrotic elements.
Keywords
ETDRSNeovascular AMDM12SRDnAMDCATTICGABCVAAMDCNVHRMCMDRPEChoroidal neovascularizationPolypoidal choroidal vasculopathyMacular atrophyIndocyanine green angiographyfluorescein angiographyELMretinal pigment epitheliumbest-corrected visual acuitySerous retinal detachmentVisual acuityearly treatment diabetic retinopathy studyage-related macular degenerationexternal limiting membraneVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)Comparison of Age-Related Macular Degeneration Treatments Trialsellipsoid zonePCV یا Pneumococcal conjugate vaccine
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Giuseppe MD, FEBO, Michael R. MSc, Francesco MD, FEBO, Usha MD, PhD,